Amber R Engel

Title: The Innovative Contributions of Amber R Engel

Introduction

Amber R Engel is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of chimeric viruses for immunological applications. With a total of 2 patents, her work is paving the way for advancements in vaccine development.

Latest Patents

Amber R Engel's latest patents focus on antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses. These patents disclose innovative chimeric TBEV/DEN4 flaviviruses that include a first nucleic acid molecule with a 5' non-coding region from a DEN4 virus. The constructs also feature a second nucleic acid molecule encoding a prM protein and an E protein from a TBEV. The E protein includes specific amino acid substitutions that enhance its efficacy. Additionally, methods for eliciting an immune response using these chimeric flaviviruses are also disclosed.

Career Highlights

Amber R Engel is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution allows her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Alexander G Pletnev and Brian R Murphy. Their collaborative efforts enhance the research output and innovation within their projects.

Conclusion

Amber R Engel's contributions to the field of biotechnology through her patents and collaborations are noteworthy. Her innovative work continues to impact vaccine development and immunological research.